Assembly Biosciences, Inc.ASMBNASDAQ
LOADING
|||
Alerts
Want to monitor ASMB?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ASMBWant to monitor ASMB?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ASMBAssembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio's approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio's strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets.